Provided by Tiger Trade Technology Pte. Ltd.

Trevi Therapeutics, Inc.

17.96
-0.2900-1.59%
Post-market: 18.150.1900+1.06%19:30 EDT
Volume:1.14M
Turnover:20.50M
Market Cap:2.55B
PE:-51.05
High:18.54
Open:18.44
Low:17.83
Close:18.25
52wk High:20.22
52wk Low:6.93
Shares:142.00M
Float Shares:118.00M
Volume Ratio:0.79
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3518
EPS(LYR):-0.3173
ROE:-19.66%
ROA:-13.82%
PB:7.93
PE(LYR):-56.60

Loading ...

BRIEF-Trevi Therapeutics Announces Proposed Public Offering Of Common Stock

Reuters
·
Apr 17

Trevi Therapeutics Shares Down 5.6% After the Bell; Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Apr 17

Trevi Therapeutics launches USD 150 million underwritten common stock offering

Reuters
·
Apr 17

Trevi Therapeutics Inc - Commences $150 Mln Underwritten Public Offering of Common Stock

THOMSON REUTERS
·
Apr 17

Press Release: Trevi Therapeutics Announces Proposed Public Offering of Common Stock

Dow Jones
·
Apr 17

Trevi Therapeutics (TRVI) Is Up 10.5% After Seeking Major Share Increase For Added Strategic Flexibility

Simply Wall St.
·
Apr 12

Trevi Therapeutics announces annual shareholder meeting plans

Reuters
·
Apr 11

Trevi Therapeutics to host investor and analyst day, join healthcare conferences

Reuters
·
Apr 01

Analysts Conflicted on These Healthcare Names: Trevi Therapeutics (TRVI), Annexon Biosciences (ANNX) and Medtronic (MDT)

TIPRANKS
·
Mar 19

Stock Track | Trevi Therapeutics Plummets 5% Intraday After Morgan Stanley Cuts Target Price

Stock Track
·
Mar 19

Stock Track | Trevi Therapeutics Soars 7.15% in Pre-Market on Positive Analyst Coverage

Stock Track
·
Mar 18

Trevi Therapeutics Inc : Morgan Stanley Cuts Target Price to $18.00 From $19.00

THOMSON REUTERS
·
Mar 18

Trevi Therapeutics (TRVI) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Mar 18

Trevi Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 18

Earnings Flash (TRVI) Trevi Therapeutics Posts Q4 Loss $-0.06, vs. FactSet Est of Loss of $-0.10

MT Newswires Live
·
Mar 18

Trevi Therapeutics Q4 net loss narrows 27.13% to USD 8.32 million

Reuters
·
Mar 18

BRIEF-Trevi Therapeutics Q4 Net Income USD -8.316 Million

Reuters
·
Mar 18

Trevi Therapeutics Q4 Operating Expenses USD 10.22 Million

THOMSON REUTERS
·
Mar 18

Press Release: Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 18

Why Trevi Therapeutics (TRVI) Is Down 17.2% After Doubling Down On Parallel IPF Cough Trials - And What's Next

Simply Wall St.
·
Mar 15